On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayAug 16, 2016 9:59 am

Cellectar Biosciences, Inc. (CLRB) Announces Corporate Highlights and Financial Results for Q2 2016

Cellectar Biosciences, Inc. (NASDAQ: CLRB) recently announced (http://nnw.fm/I70Ox) its corporate highlights for this quarter and financial results for Q2 2016, which ended on June 30 of this year. One of the company’s key accomplishments was the issuance of several patents from USPTO, including CLR 131 and other radiotherapeutics used in the treatment of cancerous cells, as well as the CLR 1600 series. In addition to these, the company shared the results of its preclinical study of 1602, and announced the completion of the first phase of the NCI SBIR fast track grant. CLRB also closed $8 million in financing and…

Continue Reading

TuesdayAug 16, 2016 9:36 am

Monaker Group, Inc. (MKGI) Enters Agreement with Trisept Solutions to Fuel Growth

Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced a new agreement with Trisept Solutions, a division of The Mark Travel Corporation. Through this partnership, Trisept will both power Monaker’s flagship NextTrip.com brand with its Synapse travel merchandising platform and distribute its alternative lodging inventory through VAX VacationAccess, Trisept’s premier travel agent portal. This agreement is expected to fuel NextTrip’s forward growth by enabling expanded product offerings and distribution in the months to come. “Trisept has the most advanced technology available for leisure vacation packaging today,” Bill Kerby, chairman and chief executive officer of Monaker, stated in this morning’s…

Continue Reading

MondayAug 15, 2016 10:18 am

Celsion Corporation (CLSN) and Zhejiang Hisun Pharmaceutical Company Expand Partnership with GEN-1 Agreement

On Tuesday August 8, 2016, Lawrenceville, New Jersey-based Celsion Corporation (NASDAQ: CLSN), a company focused on developing a portfolio of innovative cancer treatments, announced the commencement of a Technology Transfer, Manufacturing and Commercial Supply Agreement with Zhejiang Hisun Pharmaceutical Co. Ltd., a leading pharmaceutical company in China, relating to the production for clinical and commercial purposes of GEN-1, Celsion’s proprietary gene mediated IL-12 immunotherapy. The agreement comes four years after a similar one for ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin. The agreement gives Celsion a domestically-based partner as it engages with the China Food and Drug Administration (CFDA)…

Continue Reading

MondayAug 15, 2016 9:31 am

Collectors Universe, Inc. (CLCT) Enters Multi-Year Agreement with Leading Chinese Distributor of Gold and Silver Products

Collectors Universe, Inc. (NASDAQ: CLCT), a leading provider of value-added services to the high-value collectibles market, recently announced that its subsidiary, Collectors Universe (Shanghai) Company Limited, has entered into a multi-year deal with Guojin Gold Co, Ltd. (“Guojin”), a distributor of gold and silver products in China. Under the terms of this deal, CLCT’s Professional Coin Grading Service (PCGS) division will provide coin grading services to Guojin beginning in the second half of 2016 and continuing through 2020. Guojin will leverage existing bank distribution channels to dispense the graded coin products. “Our agreement with Guojin demonstrates the significant progress we…

Continue Reading

FridayAug 12, 2016 12:24 pm

Sorrento Therapeutics, Inc. (SRNE) Finalizes Private Placements worth $150 Million

On April 4, 2016, Sorrento Therapeutics, Inc. (NASDAQ: SRNE) announced that it entered into definitive agreements for up to $150 million with institutional investors and Yuhan Corporation, the company’s strategic corporate partner. Most recently, the agreements escalated and were finalized on private placements of common stocks and warrants worth $150 million. Sorrento is an antibody-centric, clinical stage biopharmaceutical company developing safe and efficient therapies for cancer and other medical requirements, as well as for autoimmune, inflammation, and oncology related diseases. In the news release, president and CEO of Sorrento Therapeutics, Inc., Dr. Henry Ji, stated, “The completion of this significant…

Continue Reading

FridayAug 12, 2016 12:11 pm

Comtech Telecommunications Corp. (CMTL) to Supply U.S. Army with Hardware

Comtech Telecommunications Corp. (NASDAQ:CMTL) recently announced that it will be supplying the U.S. Army with Secret Internet Protocol Router and Non-Secure Internet Protocol Router Access Point (SNAP) Very Small Aperture Terminal (VSAT) satellite systems. The announcement came after its Government Solutions unit received $7.6 million in funding. Comtech Telecommunications Corp. specializes in designing, developing, manufacturing, and marketing unique and innovative communications systems and services. The company’s target market does not stop at the military; CMTL’s customer base is varied and includes commercial and government organizations worldwide involved in the communications industry. In a recent news release, Dr. Stanton Sloane, president…

Continue Reading

ThursdayAug 11, 2016 3:10 pm

Aldeyra Therapeutics (ALDX) Discloses Promising Outcome from Clinical Trials of Topical Dermatologic NS2

On Tuesday, August 9, 2016, Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), a biotechnology company involved in the commercialization of products that treat diseases thought to be related to endogenous aldehydes, made public the results of a randomized, parallel-group, double-blind, vehicle-controlled, multi-center clinical trial of topical dermatologic NS2 for the treatment of the dermal manifestations of Sjögren-Larsson Syndrome (SLS). The company, which is based in Lexington, Massachusetts, first became aware of SLS in 2012 and made the decision to employ its knowledge of aldehyde traps to combat the disease. The encouraging conclusion of these clinical trials marks, therefore, a major milestone for Aldeyra…

Continue Reading

ThursdayAug 11, 2016 10:04 am

Laguna Blends, Inc. (LAGBF) Looking to Expand Pro Athlete Brand Strategy for Pro369

Before the opening bell, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (FRANKFURT: LB6A.F) offered investors an update on the success of its pro athlete branding strategy for Pro369, the company’s hemp protein-based functional beverage product. In addition to announcing the renewal of Emmanual Arceneaux, a player in the Canadian Football League, as a brand ambassador for a second year, Laguna announced that it is currently in ongoing negotiations with a number of other professional athletes across North America who enjoy the health benefits offered by Laguna’s products. In June, Laguna reported its results from the first 11 weeks of sales…

Continue Reading

ThursdayAug 11, 2016 9:12 am

ON Semiconductor Corp. (ON) Announces Offer to Purchase Outstanding Shares of Fairchild Semiconductor International

ON Semiconductor Corporation (NASDAQ: ON) recently announced an extension offer to buy the entirety of the leftover shares of Fairchild Semiconductor International, Inc. (NASDAQ: FCS) common stock for $20 cash per share, awaiting the satisfaction of the conditions of the offer, as determined in the merger agreement signed by both companies on November 18, 2015. The offer now expires at midnight Eastern Time on August 18, 2016, unless it is further extended, as permitted by the merger. As long as the terms of the offer are agreed upon, the merger agreement of the offer needs successive ten-day extensions, which ON…

Continue Reading

WednesdayAug 10, 2016 1:17 pm

Eagle Bulk Shipping, Inc. (EGLE) Well Positioned to Weather Storm or Exploit Sector Recovery with Growth

Given the Baltic Dry Index’s (BDI) all-time lows of early 2016 (http://nnw.fm/7xHSF), it is no wonder that many of the key players in the heavily fragmented global dry bulk shipping market have seen some painful quarters, with only the best of breed operations able to weather the storm. Slumping demand in the sector (roughly two-thirds of which is folks transporting iron ore and coal) has been due primarily to falloff of industrial and urbanization activity in China, enhanced by factors such as China’s mounting power overcapacity. China and India are both going greener too, with aggressive emission targets on the…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217